Two-Step Crosslinking for Polymeric Microparticle Strength
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing microcarriers used in cell culture and drug delivery technologies face challenges such as high manufacturing costs, reduced economic efficiency, and potential cell damage due to the need for proteolytic enzyme-based cell detachment processes. Additionally, biopolymers like hyaluronic acid are prone to degradation and exhibit reduced cell adhesion due to negative surface charges.
Innovation Solution
A method for preparing polymeric microparticles involves a two-step crosslinking process. First, a biocompatible polymer is crosslinked in an emulsion state with a first crosslinking agent, followed by extraction and secondary crosslinking in an organic solvent phase with a second crosslinking agent, optimizing crosslinking density and mechanical strength.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a single crosslinking step is used to simplify the process, then manufacturing complexity is reduced, but mechanical strength and crosslinking efficiency are insufficient
Solution Approach 1:
The crosslinking process is divided into two distinct steps: first crosslinking in aqueous phase followed by second crosslinking in organic solvent phase. This segmentation allows each step to optimize for different requirements, achieving high mechanical strength without excessive process complexity
Solution Approach 2:
The patent changes the solvent phase parameter between crosslinking steps (from aqueous to organic solvent) to optimize crosslinking efficiency and mechanical strength at each stage, resolving the contradiction between process simplicity and product performance
2Object-affected harmful factors
If proteolytic enzymes are used for cell detachment to maintain cell viability, then cell damage is reduced, but manufacturing cost increases and economic efficiency decreases
Solution Approach 1:
The microparticles are designed with temporary adhesion properties that allow easy detachment without expensive enzymes. The particles serve their purpose during culture and can be discarded or easily separated, eliminating the need for costly proteolytic enzymes while maintaining cell viability
Solution Approach 2:
The microparticle surface is engineered to provide self-detachment capability through controlled adhesion mechanisms, eliminating the need for external enzymatic agents and reducing manufacturing costs while protecting cell integrity
3Reliability
If hyaluronic acid is used as a biocompatible polymer to ensure biocompatibility, then biocompatibility is improved, but mechanical strength is insufficient and stability against degradation is reduced
Solution Approach 1:
The patent uses composite materials by combining hyaluronic acid with other polymers or crosslinking agents to maintain biocompatibility while significantly improving mechanical strength and degradation resistance of the microparticles
Solution Approach 2:
Crosslinking is performed preliminarily during the microparticle formation process, creating a pre-stabilized structure that maintains both biocompatibility and enhanced mechanical strength before cell culture or application
4Strength
If crosslinking density is increased to improve mechanical strength, then strength is improved, but production yield decreases
Solution Approach 1:
The patent optimizes crosslinking parameters including solvent type, crosslinking agent concentration, and reaction time to achieve high mechanical strength while maintaining acceptable production yield through parameter optimization rather than maximum crosslinking density
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting polymeric microparticles exhibit enhanced mechanical strength, stability, and high crosslinking efficiency, while also improving production yield and maintaining biocompatibility, thus addressing the limitations of existing microcarriers.
Implementation Method 1
subjecting a mixture containing a biocompatible polymer in an emulsion state and a first crosslinking agent to a primary crosslinking reaction to form crosslinked particles; and extracting the crosslinked particles and performing a secondary crosslinking reaction in an organic solvent phase including a second crosslinking agent
Implementation Method 2
adding an aqueous solution in which the biocompatible polymer is dissolved to a hydrophobic solvent to form an emulsion
Implementation Method 3
extracting the crosslinked particles and performing a secondary crosslinking reaction in an organic solvent phase
Data Source
AI summary
The present disclosure relates to a method of preparing polymeric microparticles that can realize excellent mechanical strength and stability as well as high crosslinking efficiency and production yield, polymeric microparticles, medical compositions, cosmetic compositions, medical articles and cosmetic articles comprising the same.